Pharsight

Athena patents expiration

1. Fibricor patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7915247 ATHENA Methods of use of fenofibric acid
Aug, 2027

(3 years from now)

US7569612 ATHENA Methods of use of fenofibric acid
Aug, 2027

(3 years from now)

US7741374 ATHENA Methods of use of fenofibric acid
Aug, 2027

(3 years from now)

US7741373 ATHENA Methods of use of fenofibric acid
Aug, 2027

(3 years from now)

Drugs and Companies using FENOFIBRIC ACID ingredient

Market Authorisation Date: 14 August, 2009

Treatment: Adjunctive therapy to diet in patients with hyperlipidemias; Adjunctive therapy to diet in patients with mixed dyslipidemia; Adjunctive therapy to diet to patients with hypertriglyceridemia; Adjunctiv...

Dosage: TABLET;ORAL

More Information on Dosage

FIBRICOR family patents

Family Patents

2. Nexiclon Xr patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8337890 ATHENA Modified release formulations containing drug-ion exchange resin complexes
Apr, 2027

(3 years from now)

US8623409 ATHENA Clonidine formulation
Sep, 2031

(7 years from now)

Drugs and Companies using CLONIDINE ingredient

Market Authorisation Date: 03 December, 2009

Treatment: NA

Dosage: TABLET, EXTENDED RELEASE;ORAL

More Information on Dosage

NEXICLON XR family patents

Family Patents

3. Qdolo patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US11752103 ATHENA Tramadol hydrochloride solution
Sep, 2040

(16 years from now)

US11103452 ATHENA Tramadol hydrochloride solution
Sep, 2040

(16 years from now)

Drugs and Companies using TRAMADOL HYDROCHLORIDE ingredient

Market Authorisation Date: 01 September, 2020

Treatment: Management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate

Dosage: SOLUTION;ORAL

More Information on Dosage

QDOLO family patents

Family Patents